Published: Dec 07, 2020, 05:18 IST | Updated: Dec 07, 2020, 05:18 IST
The Serum Institute of India (SII) on Sunday became the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for the Oxford COVID-19 vaccine 'Covishield' in the country,